Insider · CIK 0001672659
David Malcom Rodman
Files at MLYS (Mineralys Therapeutics, Inc.). First filing Nov 8, 2024, latest Nov 12, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MLYS: Mineralys Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Mineralys Therapeutics, Inc. | $75k 5,026 shares | -3% | - | |
| 1Weak | Mineralys Therapeutics, Inc. | $383k 25,482 shares | -16% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2024 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Common Stock | +5,017 | $0.54 | $2,709 | 146,008 | Dec 13, 2024 |
| Dec 11, 2024 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Stock Optionderivative | -5,017 | $0.00 | $0 | 5,018 | Dec 13, 2024 |
| Nov 11, 2024 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,017 | $0.54 | $2,709 | 140,991 | Nov 12, 2024 |
| Nov 11, 2024 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,026 | $1.08 | $5,428 | 146,017 | Nov 12, 2024 |
| Nov 11, 2024 | MLYS Mineralys Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,026 | $15.00 | $75k | 140,991 | Nov 12, 2024 |
| Nov 11, 2024 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Stock Optionderivative10b5-1 | -5,017 | $0.00 | $0 | 10,035 | Nov 12, 2024 |
| Nov 11, 2024 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Stock Optionderivative10b5-1 | -5,026 | $0.00 | $0 | 134,926 | Nov 12, 2024 |
| Nov 6, 2024 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +25,482 | $1.08 | $28k | 161,456 | Nov 8, 2024 |
| Nov 6, 2024 | MLYS Mineralys Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -25,482 | $15.03 | $383k | 135,974 | Nov 8, 2024 |
| Nov 6, 2024 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Stock Optionderivative10b5-1 | -25,482 | $0.00 | $0 | 139,952 | Nov 8, 2024 |
| Oct 11, 2024 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Common Stock | +5,017 | $0.54 | $2,709 | 130,622 | Oct 15, 2024 |
| Oct 14, 2024 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Common Stock | +5,352 | $1.08 | $5,780 | 135,974 | Oct 15, 2024 |
| Oct 11, 2024 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Stock Optionderivative | -5,017 | $0.00 | $0 | 15,052 | Oct 15, 2024 |
| Oct 14, 2024 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Stock Optionderivative | -5,352 | $0.00 | $0 | 165,434 | Oct 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.